Lung Cancer :: Lack of a protein in lung tumors may increase risk of death
A study of human lung tumors indicates that lung cancer patients who lack a particular protein may do more poorly than those with normal levels of that same protein.
Therapy
Heart Disease :: Long-term aspirin use reduces heart disease risk in women
Women who take low to moderate doses of aspirin have a reduced risk of death from any cause, and especially heart disease-related deaths, according to a report in the March 26 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Breast Cancer :: Aggressive breast cancers linked to young African American women
So-called ?triple negative? breast cancers, tumors that do not contain any of three significant tumor markers, are aggressive, deadly cancers that affect young, poor minority women, according to a new study.
Heart Failure :: Is there a role for serial outpatient drug infusions in advanced heart failure?
For patients with severe chronic heart failure, known as stage D or chronic decompensated heart failure (CDHF), hospitalization is frequent and treatment options are limited.
Blood Pressure :: Dual renin system blocking drug combo provides additional blood pressure-lowering effects
A combination of two medicines that act against the effects of the enzyme renin are more effective in lowering blood pressure than either of the medicines alone, according to a study presented today at the American College of Cardiology?s 56th Annual Scientific Session.
Stent :: Study identifies steps to improve safety of renal artery stenting
High blood pressure is the most common chronic medical condition in the United States, and the most common identifiable cause is narrowing of a kidney artery, called renal artery stenosis.
Diabetes :: Clinical trial for diabetic macular edema
The Juvenile Diabetes Research Foundation, the world?s largest charitable funder of type 1 diabetes research, announced that the Ranibizumab for Edema of the mAcula in Diabetes Phase 2 Study (READ 2) is now enrolling patients.
Patient :: Nova Scotia with Canada to announce patient wait times guarantee
The Honourable Tony Clement, Federal Minister of Health, and the Honourable Chris d’Entremont, Nova Scotia Health Minister, announced that Nova Scotia has agreed to establish a Patient Wait Times Guarantee in radiation therapy for cancer by 2010, to be supported by $24.2 million in federal Budget 2007 funding.
Macular Degeneration :: Zinc link to leading cause of blindness macular degeneration
An international research team led by scientists at the Institute of Ophthalmology, UCL (University College London), has found high levels of zinc in the deposits in the eye which are a marker of age-related macular degeneration (AMD), the leading cause of blindness in the elderly in the developed world.
Crohn’s Disease :: Remicade – Treatment for Pediatric Crohn’s Disease
Centocor, Inc. and Schering-Plough Corporation (NYSE: SGP) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) issued a positive opinion recommending the approval of REMICADE(R) (infliximab) for the treatment of severe, active Crohn’s disease (CD) in pediatric patients aged 6 to 17 years, who have not responded to conventional therapy including a corticosteroid, an immunomodulator and primary nutrition therapy, or who are intolerant to, or have contraindications for, such therapies.